These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 15130417

  • 1. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene].
    Yu YM, Hou FF, Zhang X, Zhou H, Liu ZQ.
    Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417
    [Abstract] [Full Text] [Related]

  • 2. [The role of hyperhomocysteinemia on atherosclerosis in patients with chronic renal failure].
    Yu Y, Hou F, Zhou H, Yang Y, Zhang X, Yang L, Hu M.
    Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):517-21. PubMed ID: 12421497
    [Abstract] [Full Text] [Related]

  • 3. [Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease].
    Yang XB, Hou FF, Wu Q, Zhou H, Liu ZR, Yang Y, Zhang X.
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):342-6. PubMed ID: 16009002
    [Abstract] [Full Text] [Related]

  • 4. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.
    Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T.
    Kidney Int; 1999 May; 55(5):1899-911. PubMed ID: 10231453
    [Abstract] [Full Text] [Related]

  • 5. [Relationship between cardiovascular complication and inflammation, oxidative stress of patient with maintenance hemodialysis].
    Zuo C, Qiu HY, Li Z, Xie XS, Fan JM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):119-21, 129. PubMed ID: 18390217
    [Abstract] [Full Text] [Related]

  • 6. Homocysteine and carotid atherosclerosis in chronic renal failure--the confounding effect of renal function.
    Leskinen Y, Lehtimäki T, Loimaala A, Huhtala H, Salenius JP, Oja SS, Saha H.
    Atherosclerosis; 2004 Aug; 175(2):315-23. PubMed ID: 15262188
    [Abstract] [Full Text] [Related]

  • 7. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM, Kandell NF, El-Shamaa AA, Harba TM, Abdel-Hady AA.
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [Abstract] [Full Text] [Related]

  • 8. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
    Ozdemir G, Ozden M, Maral H, Kuskay S, Cetinalp P, Tarkun I.
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117
    [Abstract] [Full Text] [Related]

  • 9. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 10. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y, Liu H, Liu F, Ouyang L, Cheng M, Gao L, Pan F, Liu Y, Chen X, Li J.
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [Abstract] [Full Text] [Related]

  • 11. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
    McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST.
    Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
    [Abstract] [Full Text] [Related]

  • 12. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.
    Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M, Tagle R, González F, Quiroga T, Caceres MS, Leighton F, Pereira J.
    Kidney Int; 2001 Nov; 60(5):1844-50. PubMed ID: 11703602
    [Abstract] [Full Text] [Related]

  • 13. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M.
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [Abstract] [Full Text] [Related]

  • 14. Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.
    Haraki T, Takegoshi T, Kitoh C, Kajinami K, Wakasugi T, Hirai J, Shimada T, Kawashiri M, Inazu A, Koizumi J, Mabuchi H.
    Clin Nephrol; 2001 Aug; 56(2):132-9. PubMed ID: 11522090
    [Abstract] [Full Text] [Related]

  • 15. Influence of oxidative stress and inflammation on rHuEPO requirements of hemodialysis patients with CRP values "in normal range".
    Tutal E, Sezer S, Bilgic A, Aldemir D, Turkoglu S, Demirel O, Ozdemir N, Haberal M.
    Transplant Proc; 2007 Dec; 39(10):3035-40. PubMed ID: 18089316
    [Abstract] [Full Text] [Related]

  • 16. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
    Suliman ME, Stenvinkel P, Heimbürger O, Bàràny P, Lindholm B, Bergström J.
    Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
    [Abstract] [Full Text] [Related]

  • 17. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H, Feki M, Hsairi M, Sanhaji H, Kaabachi N, Ben Abdallah T, Massy ZA, Ben Maiz H, Lacour B, Mebazaa A.
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [Abstract] [Full Text] [Related]

  • 18. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V, Kes P, Reiner Z.
    Acta Med Croatica; 2006 May; 60(1):21-6. PubMed ID: 16802568
    [Abstract] [Full Text] [Related]

  • 19. Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results.
    Zoungas S, Branley P, Kerr PG, Ristevski S, Muske C, Demos L, Atkins RC, Becker G, Fraenkel M, Hutchison BG, Walker R, McNeil JJ, McGrath BP.
    Nephrology (Carlton); 2004 Jun; 9(3):130-41. PubMed ID: 15189174
    [Abstract] [Full Text] [Related]

  • 20. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B, Anderstam B, Suliman M, Alvestrand A.
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.